Medicaid Launches Innovative Payment Model to Expand Access to Sickle Cell Gene Therapies
The U.S. Medicaid program has taken a pioneering step to ensure that new gene therapies for sickle cell disease (SCD) are accessible to the millions of Americans who rely on…